MassMutual Private Wealth & Trust’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.32K Sell
246
-16
-6% -$128 ﹤0.01% 1902
2026
Q2
$2.29K Buy
+262
New +$1.98K ﹤0.01% 1968

Other funds holding IBRX

MassMutual Private Wealth & Trust's IBRX Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its ImmunityBio (IBRX) stake by 6.1% in Q3 2026, selling an estimated $128 and leaving 246 shares worth $2.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1902.

MassMutual Private Wealth & Trust first reported a position in IBRX in Q2 2026 and has held it in 2 quarters since. 406 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • MassMutual Private Wealth & Trust held 246 shares of ImmunityBio worth $2.32K as of Q3 2026.
  • MassMutual Private Wealth & Trust sold 16 ImmunityBio shares in Q3 2026, an estimated $128.
  • ImmunityBio made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1902 holding.
  • MassMutual Private Wealth & Trust first reported a position in ImmunityBio in Q2 2026 and has held it in 2 quarters since.
  • 406 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.